Treatment of HIV-related scabies with emphasis on the efficacy of ivermectin.
Semin Cutan Med Surg
; 16(3): 235-40, 1997 Sep.
Article
en En
| MEDLINE
| ID: mdl-9300635
ABSTRACT
Since the mid-1980s, worldwide reports confirm that scabies in individuals infected with the human immunodeficiency virus (HIV) result in a wide range of-clinical manifestations which differ from those seen in immunocompetent patients. There is also general agreement that HIV-related scabies is more difficult to treat. Oral ivermectin has been shown in several countries to be a safe and effective therapy. In otherwise healthy persons, one dose of 200 microg/kg is usually curative. In HIV-related scabies, one treatment may be curative but repeated doses may be required. Crusted scabies in these individual requires a combination of oral ivermectin, total body treatments with 5% permethrin cream, and keratolytic agents to hasten removal of crusts.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Escabiosis
/
Ivermectina
/
Infecciones Oportunistas Relacionadas con el SIDA
/
Insecticidas
Tipo de estudio:
Diagnostic_studies
Límite:
Female
/
Humans
/
Male
Idioma:
En
Revista:
Semin Cutan Med Surg
Asunto de la revista:
DERMATOLOGIA
Año:
1997
Tipo del documento:
Article
País de afiliación:
Estados Unidos